Construction of Chimeric JEV E-Bindingdomain Plasmid in Methylotrophic Yeast Pichia pastoris

Chen Pu-yan
2005-01-01
Progress in Biotechnology
Abstract:Hsp70 contains an N-terminal 44kDa ATPase portion(HSP701-358) and a C-terminal 28kDa portion (HSP70359-610) .which contains the 18kDa peptide binding domain(aa359 -540) .Constructing a chimeric vector of major antigenic seg- ment of E protein and binding domain in methylotrophic yeast Pichia pastoris was prepared to examine whether binding domain can enhance the immunogenicity of major antigenic segment of E protein. The vector was constructed by routine mole- cular technique. Fusion genes were linked with a restriction site BamHI. Vectors were transformed into yeast X-33 by electroporation. The recombinant transformants were selected by Zeocin. Expression of the fusion protein in yeast was induced by the addition of methanol and analysed by SDS-PAGE and western blot. The chimeric vector was constructed successfully. Relative molecular mass (Mr) of the fusion protein was sized about 68kDa. The protein was produced at a yield of 97 mg per litter of culture and has specific antigenicity. To examine cell and body immune response after BALB/c mice were immunized with E-BD fusion protein expressed in Pichia pastoris . Mice were immunized i.p. on day 0 and day 21 .We measured proliferation of lymphocytes by MTT and determined liters of antibody by ELISA. These data tell us the fusion protein is a more powerful antigen than major antigenic segment of JEV E protein alone. The effectiveness of binding domain in eliciting a humoral and cellular response to an attached antigenic peptide in the absense of adjuvant was illustrated and affirms the potential utility of bindingdomain in vaccine development.
What problem does this paper attempt to address?